Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2019 | Targeted therapy in TNBC

Peter Schmid, MD, PhD, FRCP, Barts Cancer Institute, London, UK gives an outline of targeted therapies for triple-negative breast cancer (TNBC) including neoadjuvant treatment in order to increase path CR. This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.